Cargando…
Oxymatrine relieves high-fructose/fat-induced obesity via reprogramming the activity of lipid metabolism-related enhancer
INTRODUCTION: Emerging evidence demonstrates that the high-fructose and high-fat diet (HFHF) induced obesity and fatty liver disease has become one of the most common metabolic disorders worldwide. Therefore, innovative investigations on compounds targeting obesity and fatty liver diseases are urgen...
Autores principales: | Ren, Luping, Liu, Xuehua, Huang, Xitong, Zhang, He, Fei, Wenjie, Yu, Xian, Hu, Zhijuan, Zhen, Yunfeng, Chen, Shuchun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437059/ https://www.ncbi.nlm.nih.gov/pubmed/37600712 http://dx.doi.org/10.3389/fendo.2023.1145575 |
Ejemplares similares
-
Effects of semaglutide on vascular structure and proteomics in high-fat diet-induced obese mice
por: Yue, Lin, et al.
Publicado: (2022) -
Fructose Consumption During Pregnancy Influences Milk Lipid Composition and Offspring Lipid Profiles in Guinea Pigs
por: Smith, Erin Vanessa LaRae, et al.
Publicado: (2020) -
Distinct impacts of fat and fructose on the liver, muscle, and adipose tissue metabolome: An integrated view
por: Meneses, Maria João, et al.
Publicado: (2022) -
Proteomic analysis reveals semaglutide impacts lipogenic protein expression in epididymal adipose tissue of obese mice
por: Zhu, Ruiyi, et al.
Publicado: (2023) -
Identification of the Chinese Population That Can Benefit Most From Postprandial Lipid Testing: Validation of the Use of Oral Fat Tolerance Testing in Clinical Practice
por: Hou, Xiaoyu, et al.
Publicado: (2022)